JP2025504036A5 - - Google Patents
Info
- Publication number
- JP2025504036A5 JP2025504036A5 JP2024544968A JP2024544968A JP2025504036A5 JP 2025504036 A5 JP2025504036 A5 JP 2025504036A5 JP 2024544968 A JP2024544968 A JP 2024544968A JP 2024544968 A JP2024544968 A JP 2024544968A JP 2025504036 A5 JP2025504036 A5 JP 2025504036A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- nanobody
- item
- nirgsygntyysr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263304954P | 2022-01-31 | 2022-01-31 | |
| US63/304,954 | 2022-01-31 | ||
| PCT/US2023/061658 WO2023147588A2 (en) | 2022-01-31 | 2023-01-31 | Enhanced-affinity anti-ecm nanobody-cytokine fusions and their applications |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025504036A JP2025504036A (ja) | 2025-02-06 |
| JP2025504036A5 true JP2025504036A5 (https=) | 2026-02-09 |
Family
ID=87472533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544968A Pending JP2025504036A (ja) | 2022-01-31 | 2023-01-31 | 親和性が増強された抗ｅｃｍナノボディ－サイトカイン融合体およびその応用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230295284A1 (https=) |
| EP (1) | EP4473015A2 (https=) |
| JP (1) | JP2025504036A (https=) |
| CN (1) | CN118660909A (https=) |
| AU (1) | AU2023211706A1 (https=) |
| WO (1) | WO2023147588A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116143945A (zh) * | 2022-12-09 | 2023-05-23 | 浙江大学杭州国际科创中心 | 一种趋化因子与免疫检查点抑制剂融合表达蛋白及其生产方法和应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220175833A1 (en) * | 2019-03-07 | 2022-06-09 | Children's Medical Center Corporation | Targeted delivery of immune-modulating vhh and vhh-fusion protein |
-
2023
- 2023-01-31 US US18/162,512 patent/US20230295284A1/en active Pending
- 2023-01-31 JP JP2024544968A patent/JP2025504036A/ja active Pending
- 2023-01-31 AU AU2023211706A patent/AU2023211706A1/en active Pending
- 2023-01-31 WO PCT/US2023/061658 patent/WO2023147588A2/en not_active Ceased
- 2023-01-31 EP EP23747968.8A patent/EP4473015A2/en active Pending
- 2023-01-31 CN CN202380019368.XA patent/CN118660909A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | Insulin-like growth factor 2 (IGF2)-fused lysosomal targeting chimeras for degradation of extracellular and membrane proteins | |
| CN110913871B (zh) | 生成哺乳动物t细胞活化诱导型合成启动子(syn+pro)以改善t细胞疗法 | |
| WO2019175428A1 (en) | Cell-mediated exosome delivery | |
| JP2021167329A5 (https=) | ||
| CN116134139B (zh) | 一种转基因免疫效应细胞及其应用 | |
| US20260083866A1 (en) | Compositions targeting endothelial cells and uses thereof | |
| CN117304315B (zh) | 抗il-6的纳米抗体及其在il-6相关疾病中的应用 | |
| Fercher et al. | Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins | |
| EP4155404A1 (en) | Blood-brain barrier penetrating aptamer, and use thereof | |
| Gras et al. | Changes in gene expression pattern of human primary macrophages induced by carbosilane dendrimer 2G-NN16 | |
| CN117186220A (zh) | 可结合白介素31的抗体或其抗原结合片段及其制备方法和应用 | |
| CN118496355A (zh) | 抗血清白蛋白的纳米抗体及其衍生物和应用 | |
| JP7839238B2 (ja) | ｍＲＮＡディスプレイ抗体ライブラリー及び方法 | |
| JP2025504036A5 (https=) | ||
| CN117986360B (zh) | Il18蛋白的特异性抗体及其制备方法与应用 | |
| CA3180251A1 (en) | Cytokine conjugates | |
| Vorobyeva et al. | Aptamers against immunologic targets: Diagnostic and therapeutic prospects | |
| CN117964760B (zh) | 抗人cll1/cd3的双特异性抗体及其应用 | |
| CN119176877B (zh) | 一种靶向b细胞cd20的纳米抗体及其应用 | |
| CN106928358B (zh) | 一种CD105纳米抗体Nb168 | |
| Mukai et al. | IL-12 plays a pivotal role in LFA-1-mediated T cell adhesiveness by up-regulation of CCR5 expression | |
| CN120399071A (zh) | 一种靶向TfR1的单域抗体及其应用 | |
| CN121152799A (zh) | 抗白介素18受体的纳米抗体及其应用 | |
| CN119613545B (zh) | 非天然氨基酸修饰的抗ccl5纳米抗体 | |
| CN106928355A (zh) | 一种CD105纳米抗体Nb184 |